Filter posts

Invest in Diversity to Drive Innovation

“We’re just looking for someone with the right ‘fit.’”  How many times have you heard …

U.S. Department of Defense Officials Introduce New Strategies to Stimulate Medical Countermeasures D...

For the past several years, BIO has had the opportunity to partner with the U.S. …

Start-Up CEO: Making the Choices to Develop a Novel Medicine

The choices surrounding research investment and drug development are daunting for even the most experienced …

BIO2017: Tuesday’s Exhibit Show Floor Finds

  With over 1,800 exhibitors at BIO2017, there is truly something for everyone.  From a …

“High Tech Enables High Touch.” Stanford’s Dean of Medicine on How Technology is Changing the ...

Dean Lloyd Minor says technology, and specifically, smartphones are making healthcare deliverable in real-time. By …

What’s Your Bio Strategy?

John Cumbers, founder of SynBioBeta, introduced today’s biofuels and renewable chemicals track at the 2017 …

One Health Holds the Key to Preventing the Next Pandemic

Can we combat disease threats before they even emerge?  In the fight against infectious diseases, …

100 Breakthrough Cancer Inventions from 100 Companies? BIO and CAI are Betting On It

There are more than 150,000 inventions that are “sitting on the shelf – because of …

New EDC Research Cracks the Code of the San Diego Genomics Industry

A news conference followed by a panel discussion with local experts today released the first …

Alnylam CEO John Maraganore Takes the Reins as BIO Chair

John Maraganore, CEO of Cambridge-based Alnylam Pharmaceuticals, begins his chairmanship of BIO this morning when …